Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
TIM's: Trying to Draw Comparisons
San Francisco -- Results of a study evaluating topical tacrolimus ointment 0.03 percent (Protopic) indicate it is a safe and effective treatment for patients of all ages with mild to moderate atopic dermatitis (AD), John Y M Koo, M.D., said at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
